Plasma 5-aminolevulinic acid concentration and lead exposure in children

Environmental Research

Volumn 80, Issue 1, 1999, Pages 41-49

  Sithisarankul, Pornchai ^a   Cadorette, Maureen ^b   Davoli, Cecilia T ^c   Serwint, Janet R ^c   Chisolm Jr , James J ^c   Strickland, Paul T ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ERYTHROCYTE PROTOPORPHYRIN; LEAD;

ARTICLE; CHEMICAL ANALYSIS; CHILD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LEAD BLOOD LEVEL; LEAD POISONING; PRIORITY JOURNAL;

EID: 0032929409     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1006/enrs.1998.3883     Document Type: Article

References (46)

1. Kappas A., Sassa S., Galbraith R. A., Nordmann Y. The porphyrias. The Metabolic and Molecular Bases of Inherited Disease. 2:1995;McGraw-Hill, New York. p. 2103-2159.
2. Muller W. E., Snyder S. H. δ Ann. Neurol. 2:1997;340-342.
3. Brennan M. J. W., Cantrill R. C. δ Nature. 280:1979;514-515.
4. Brennan M. J. W., Cantrill R. C. Delta-aminolevulinic acid and amino acid neurotransmitters. Mol. Cell Biochem. 38:1981;49-58.
5. Audesirk G. Effects of lead exposure on the physiology of neurons. Prog. Neurobiol. 24:1985;199-231.
6. Cutler M. G., McLaughlin M., McNeil E., Moore M. R. Effects of delta-aminolevulinic acid on contractile activity in the isolated small intestine of the rabbit. Neuropharmacology. 24:1985;1005-1009.
7. Silbergeld E. K., Lamon J. M. Role of altered heme synthesis in lead neurotoxicity. J. Occup. Med. 22:1980;680-684.
8. Silbergeld E. K., Lamon J. M. Effects of altered porphyrin synthesis on brain neurochemistry. Neurobehav. Toxicol. Teratol. 4:1982;635-642.
9. Bonkowsky H. L., Schady W. Neurologic manifestations of acute porphyria. Semin. Liver Dis. 2:1982;108-124.
10. Yeung Laiwah A. C., Moore M. R., Goldberg A. Pathogenesis of acute porphyria. Q. J. Med. New Ser. 63:1987;377-392.
11. Bloomer J. R., Bonkovsky H. L. The porphyrias: Dis. Month. 35:1989;1-54.
12. McGillion F. B., Thompson G. G., Moore M. R., Goldberg A. The passage ofδ Biochem. Pharmacol. 23:1974;472-474.
13. Doss M., von Tiepermann R., Schneider J., Schmid H. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin. Wochensch. 57:1979;1123-1127.
14. Thunell S., Holmberg L., Lundgren J. Aminolevulinate dehydratase porphyria in infancy. A clinical and biochemical study. J. Clin. Chem. Clin. Biochem. 25:1987;5-14.
15. Hassoun A., Verstraeten L., Mercelis R., Martin J. J. Biochemical diagnosis of an hereditary aminolevulinate dehydratase deficiency in a 63-year-old man. J. Clin. Chem. Clin. Biochem. 27:1989;781-786.
16. Doss M., Becker U., Sixel F., Geisse S., Solcher H., Schneider J., Kufner G. Persistent protoporphyrinemia in hereditary porphobilinogen synthase (δ Klin. Wochenschr. 60:1982;599-606.
17. Doss M., Laubenthal F., Stoeppler M. Lead poisoning in inheritedδ Int. Arch. Occup. Environ. Health. 54:1984;55-63.
18. Mauzerall D., Granick S. The occurrence and determination ofδ J. Biol. Chem. 219:1956;435-446.
19. Urata G., Granick S. (Determination ofδ J. Biol. Chem. 238:1963;811-820.
20. Chisolm J. J. Jr. Determination ofδ Anal. Biochem. 22:1968;54-64.
21. Bloomer J. R., Bonkovsky H. L. The porphyrias. Dis. Month. 35:1989;1-54.
22. Morita Y., Araki S., Sakai T., Araki T., Masuyama Y. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: A sensitive indicator of lead effects. Ind. Health. 32:1994;85-96.
23. CDC (Centers for Disease Control), 1991, Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control, U.S. Dept. of Health and Human Services.
24. Meisch H. U., Reinle W., Wolf U. Determination of 5-aminolevulinic acid in biological samples by high-performance liquid chromatography. Anal. Biochem. 149:1985;29-34.
25. Ho J., Guthrie R., Teickelmann H. Detection ofδ J. Chromatogr. 375:1986;57-63.
26. Minder E. I. Measurement of 5-aminolevulinic acid by reversed phase HPLC and fluorescence detection. Clin. Chim. Acta. 161:1986;11-18.
27. Meisch H. U., Wannemacher B. Fluorometric determination of 5-aminolevulinic acid after derivatization with o-phthaldialdehyde and separation by reversed-phase high-performance liquid chromatography. Anal. Chem. 58:1986;1372-1375.
28. Okayama A., Lim K. M., Goto S. Fluorophotometric determination ofδ Igakuno Ayumi. 139:1986;845-846.
29. Tomokuni K., Ichiba M., Hirai Y., Hasegawa T. Optimized liquid-chromatographic method for fluorometric determination of urinaryδ Clin. Chem. 33:1987;1665-1667.
30. Tomokuni K., Ichiba M., Hirai Y. Measurement of urinaryδ Ind. Health. 30:1992;119-128.
31. Hosoda K., Sakurai H., Omae K., Kamakura M., Satoh T. δ Sangyo Igaku. 31:1989;240-241.
32. Tomokuni K., Ichiba M., Hirai Y. HPLC micromethod for determiningδ Clin. Chem. 39:1993;169-170.
33. Tomokuni K., Ichiba M., Fujishiro K. Interrelation between urinaryδ Ind. Health. 31:1993;51-57.
34. Bannon D. I., Murashchik C., Zapf C. R., Farfel M. R., Chisolm J. J. Jr. Graphite furnace atomic absorption spectroscopic measurement of blood lead in matrix-matched standards. Clin. Chem. 40:1994;1730-1734.
35. Chisolm J. J., Brown D. H. Micro-scale photofluorometric determination of free erythrocyte porphyrin (proto-porphyrin IX). Cooper G. R. Selected Methods of Clinical Chemistry. 1977;163-177 DC. AACC Press, Washington.
36. Sithisarankul P., Schwartz B. S., Lee B. K., Kelsey K. T., Strickland P. T. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am. J. Ind. Med. 32:1997;15-20.
37. 2. Am. J. Hum. Genet. 49:1991;757-763.
38. Wetmur J. G., Lehnert G., Desnick R. J. Theδ Environ. Res. 56:1991;109-119.
39. Astrin K. H., Bishop D. F., Wetmur J. G., Kaul B., Davidow B., Desnick R. J. δ Ann. N.Y. Acad. Sci. 514:1987;23-29.
40. Benkmann H. G., Bogdanski P., Goedde H. W. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum. Hered. 33:1983;62-64.
41. Hannan C. J. Jr., Kettler T., Dabe I., Clark T. δ Clin. Chem. 35:1989;1998.
42. Morita Y., Sakai T., Araki S., Araki T., Masuyama Y. Usefulness ofδ Sangyo Igaku. 35:1993;112-118.
43. Morita Y., Sakai T., Araki S., Araki T., Masuyama Y. Studies on the determination ofδ Jpn. J. Ind. Health. 35:1993;538-539.
44. Chisolm J. J., Mellits E. D., Barrett M. B. Interrelationships among blood lead concentration, quantitative daily ALA-U, and urinary lead output following calcium EDTA. Nordberg G. F. Effects and Dose-Response Relationships of Toxic Metals. 1976;416-433 Elsevier, Amsterdam.
45. Schwartz B. S., Lee B. K., Stewart W., Sithisarankul P., Strickland P. T., Ahn K. D., Kelsey K. T. δ Occup. Environ. Med. 54:1997;241-246.
46. Silbergeld E. K. Porphyrins as indicators of chemical injury and exposure. Ann. N.Y. Acad. Sci. 514:1987;170-171.